All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kmartfit on TikTok · 14s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What is my dosage of end chlamorrhine while on testosterone replacement therapy?
  2. 0:03I take 25 milligrams three times a week and this completely keeps my
  3. 0:06bulge from shrinking and helps me maintain fertility while on TRT.
  4. 0:10For more TRT tips, hit the follow button and I'll see you on the inside.

@kmartfit's enclomiphene dosing claims need more context

KMART

TikTok creator

19.1K viewsWatch on TikTok

Quick answer

Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis. The creator presents a specific dosing protocol (25mg three times weekly) drawn from personal use rather than published guidelines or physician direction. Concurrent use of enclomiphene with exogenous testosterone remains understudied in peer-reviewed literature, and outcomes including testicular atrophy prevention have not been definitively established at this dose or schedule.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kmartfit's enclomiphene dosing claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@kmartfit's enclomiphene dosing claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kmartfit's enclomiphene dosing claims need more context" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis.

The reason this review is not generic is the source wording and the canonical claim label "trt what s my dosage of enclomiphene while on testosterone repla." In this clip, the useful excerpt is: "What is my dosage of end chlamorrhine while on testosterone replacement therapy?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Wiehle et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Enclomiphene is a selective estrogen receptor modulator used off-label by some clinicians as an adjunct to TRT to partially preserve gonadotropin signaling, testicular volume, and spermatogenesis. The creator presents a specific dosing protocol (25mg three times weekly) drawn from personal use rather than published guidelines or physician direction. Concurrent use of enclomiphene with exogenous testosterone remains understudied in peer-reviewed literature, and outcomes including testicular atrophy prevention have not been definitively established at this dose or schedule.
  • Enclomiphene is not FDA-approved in the US; it is available only through compounding pharmacies via off-label prescriptions, a fact the video omits entirely.
  • Wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in non-TRT users, not at the three-times-weekly schedule the creator promotes.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Enclomiphene is not FDA-approved in the US; it is available only through compounding pharmacies via off-label prescriptions, a fact the video omits entirely.
  • Wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in non-TRT users, not at the three-times-weekly schedule the creator promotes.
  • hCG (human chorionic gonadotropin) has more published evidence for preserving testicular function and fertility during TRT than enclomiphene does in this context.
  • A 2020 review by Patel et al. (Therapeutic Advances in Urology) flagged SERM use concurrent with exogenous androgens as under-studied, meaning safety and efficacy data are genuinely incomplete.
  • Testicular atrophy on TRT is multifactorial; no compound has been shown to completely prevent it, making the creator's 'completely' claim an overstatement not backed by evidence.
  • Anyone considering enclomiphene as a TRT adjunct should have LH, FSH, and semen analysis monitored, not just testosterone, to assess whether gonadotropin signaling is actually being preserved.
  • Self-reported personal dosing protocols on social media, however well-intentioned, are not substitutes for individualized clinical assessment, especially for off-label drug combinations.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kmartfit actually say?

The creator says they personally take "25 milligrams three times a week" of what they call "end chlamorrhine" (enclomiphene) while on TRT, and that this dose "completely keeps my bulge from shrinking" and helps maintain fertility. That's three specific claims packed into about 15 seconds: a dose, a testicular volume effect, and a fertility benefit. Let's take them apart.

To be clear about terminology: enclomiphene is the trans-isomer of clomiphene citrate. It works as a selective estrogen receptor modulator (SERM) that blocks hypothalamic estrogen feedback, triggering the release of LH and FSH. Those gonadotropins then signal the testes to produce testosterone and continue sperm production, even when exogenous testosterone would otherwise suppress that axis. The mechanism is real and reasonably well understood.

Does the science back this up?

Partially, but the confidence in that specific dosing protocol is much weaker than the creator implies. The fertility-preservation angle has some legitimate backing. The testicular shrinkage claim has less direct evidence specifically for enclomiphene on TRT.

Kim et al. (2013, Fertility and Sterility) showed clomiphene citrate restored spermatogenesis in hypogonadal men, and since enclomiphene is the active isomer, there's biological plausibility for the fertility argument. Wiehle et al. (2013, The Aging Male) looked at enclomiphene specifically and found it raised LH, FSH, and testosterone in hypogonadal men. But these studies were in men not already on exogenous testosterone. Using enclomiphene concurrently with TRT is a different scenario, one that has far less clinical trial data behind it.

The 25mg three-times-weekly dose is not from a published guideline. It appears to be a community-derived protocol circulating in TRT forums and optimization circles. That doesn't automatically make it wrong, but it means the creator is presenting personal experimentation as if it were established practice.

What did they get wrong (or right)?

The creator gets the general concept right: exogenous testosterone suppresses the HPG axis, reducing LH and FSH, which causes testicular atrophy and impairs spermatogenesis. Using a SERM to partially rescue gonadotropin signaling while on TRT is a real clinical strategy. Some physicians do prescribe this combination, particularly for men who want to preserve fertility options.

What they get wrong is the certainty. Saying enclomiphene "completely" prevents testicular shrinkage is not supported by evidence. Testicular volume on TRT depends on multiple factors, including baseline size, duration of use, and individual HPG sensitivity. There is no published study demonstrating complete prevention of testicular atrophy with this combination at this dose.

The dose itself is a problem to broadcast. Presenting a personal dose as a general answer to "what is my dosage" implies it applies broadly. Enclomiphene dosing in clinical studies has ranged from 12.5mg to 25mg daily, not three times weekly, and those studies were not in men on concurrent TRT. The pharmacokinetics in that combined context have not been well characterized in peer-reviewed literature.

What should you actually know?

If you're on TRT and concerned about fertility or testicular atrophy, you have real options, but they require an actual clinical conversation, not a TikTok protocol. Human chorionic gonadotropin (hCG) has a longer track record for this purpose and is the more commonly studied option. Enclomiphene as an adjunct to TRT is an area of genuine clinical interest but is not yet standard of care.

A 2020 review by Patel et al. (Therapeutic Advances in Urology) noted that while SERMs show promise for male hypogonadism, concurrent use with exogenous androgens remains under-studied. Any man considering this combination should have FSH, LH, and semen analysis monitored, not just testosterone levels.

The broader issue here is that this video is structured as a dosing recommendation from a non-clinician, delivered with total confidence, to an audience that may take it as medical guidance. That's a legitimate concern regardless of whether the underlying concept has any merit.

Is enclomiphene even legally prescribed for this use?

That depends heavily on where you are. Enclomiphene is not FDA-approved as a standalone drug in the United States. The branded version (Androxal) completed Phase III trials but was not approved. Enclomiphene is available through compounding pharmacies in the US, prescribed off-label by some men's health and urology clinicians. It is not an over-the-counter supplement. Anyone sourcing it outside a licensed prescriber is operating in legally and medically murky territory, and the creator makes no mention of this context at all.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KMART · TikTok creator

19.1K views on this video

What’s My Dosage of Enclomiphene While on Testosterone Replacement Therapy? If you’re on TRT and wondering how to maintain fertility and avoid testicular shrinkage, here’s what I do: I take 25 mg of

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about enclomiphene?

Enclomiphene is not FDA-approved in the US; it is available only through compounding pharmacies via off-label prescriptions, a fact the video omits entirely.

What does the video say about wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in?

Wiehle et al. (2013) studied enclomiphene at 12.5-25mg daily in non-TRT users, not at the three-times-weekly schedule the creator promotes.

What does the video say about hcg (human chorionic gonadotropin) has more published evidence for preserving?

hCG (human chorionic gonadotropin) has more published evidence for preserving testicular function and fertility during TRT than enclomiphene does in this context.

What does the video say about a 2020 review by patel et al. (therapeutic advances in?

A 2020 review by Patel et al. (Therapeutic Advances in Urology) flagged SERM use concurrent with exogenous androgens as under-studied, meaning safety and efficacy data are genuinely incomplete.

What does the video say about testicular atrophy on trt?

Testicular atrophy on TRT is multifactorial; no compound has been shown to completely prevent it, making the creator's 'completely' claim an overstatement not backed by evidence.

What does the video say about anyone considering enclomiphene as a trt adjunct should have lh,?

Anyone considering enclomiphene as a TRT adjunct should have LH, FSH, and semen analysis monitored, not just testosterone, to assess whether gonadotropin signaling is actually being preserved.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.